Koch Marco
Medical Faculty, Institute of Anatomy, University of LeipzigLeipzig, Germany.
Front Neurosci. 2017 May 24;11:293. doi: 10.3389/fnins.2017.00293. eCollection 2017.
Cannabinoids are lipid messengers that modulate a variety of physiological processes and modify the generation of specific behaviors. In this regard, the cannabinoid receptor type 1 (CB) represents the most relevant target molecule of cannabinoids so far. One main function of central CB signaling is to maintain whole body energy homeostasis. Thus, cannabinoids functionally interact with classical neurotransmitters in neural networks that control energy metabolism and feeding behavior. The promotion of CB signaling can increase appetite and stimulate feeding, while blockade of CB suppresses hunger and induces hypophagia. However, in order to treat overeating, pharmacological blockade of CB by the inverse agonist rimonabant not only suppressed feeding but also resulted in psychiatric side effects. Therefore, research within the last decade focused on deciphering the underlying cellular and molecular mechanisms of central cannabinoid signaling that control feeding and other behaviors, with the overall aim still being the identification of specific targets to develop safe pharmacological interventions for the treatment of obesity. Today, many studies unraveled the subcellular localization of CB and the function of cannabinoids in neurons and glial cells within circumscribed brain regions that represent integral parts of neural circuitries controlling feeding behavior. Here, these novel experimental findings will be summarized and recent advances in understanding the mechanisms of CB-dependent cannabinoid signaling being relevant for central regulation of feeding behavior will be highlighted. Finally, presumed alternative pathways of cannabinoids that are not driven by CB activation but also contributing to control of feeding behavior will be introduced.
大麻素是一类脂质信使,可调节多种生理过程并改变特定行为的产生。在这方面,1型大麻素受体(CB1)是迄今为止大麻素最相关的靶分子。中枢CB信号传导的一个主要功能是维持全身能量稳态。因此,大麻素在控制能量代谢和进食行为的神经网络中与经典神经递质发生功能性相互作用。促进CB信号传导可增加食欲并刺激进食,而阻断CB则抑制饥饿并诱导食欲减退。然而,为了治疗暴饮暴食,用反向激动剂利莫那班对CB进行药理学阻断不仅抑制了进食,还导致了精神方面的副作用。因此,过去十年的研究集中在解读控制进食和其他行为的中枢大麻素信号传导的潜在细胞和分子机制上,总体目标仍然是确定特定靶点,以开发治疗肥胖症的安全药理学干预措施。如今,许多研究揭示了CB1在亚细胞水平的定位以及大麻素在构成控制进食行为神经回路组成部分的特定脑区内神经元和神经胶质细胞中的功能。在此,将总结这些新的实验发现,并强调在理解与进食行为中枢调节相关的CB1依赖性大麻素信号传导机制方面的最新进展。最后,将介绍大麻素可能存在的替代途径,这些途径并非由CB1激活驱动,但也有助于控制进食行为。